NCT00275938View on ClinicalTrials.gov

Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis B

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

October 31, 1998

Study Completion Date

June 30, 2001

Conditions

Chronic Hepatitis B

Interventions

DRUG

interferon alpha 2b plus ribavirin

DRUG

interferon alpha 2b plus placebo

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

National Taiwan University Hospital

OTHER